Literature DB >> 18339870

Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells.

Cassin Kimmel Williams1, Marta Segarra, Maria De La Luz Sierra, Richard C A Sainson, Giovanna Tosato, Adrian L Harris.   

Abstract

Gene-targeting studies have shown that Delta-like 4 (Dll4) is required for normal embryonic vascular remodeling, but the mechanisms underlying Dll4 regulatory functions are not well defined. We generated primary human umbilical vascular endothelial cells that express Dll4 protein to study Dll4 function and previously showed that Dll4 down-regulates vascular endothelial growth factor (VEGF) receptor 2 and NRP1 expression and inhibits VEGF function. We now report that expression of Dll4 in endothelial cells inhibited attachment and migration to stromal-derived growth factor 1 (SDF1) chemokine. Cell surface, total protein, and mRNA levels of CXCR4, principal signaling receptor for SDF1, were significantly decreased in Dll4-transduced endothelial cells, attributable to a significant reduction of CXCR4 promoter activity. An immobilized recombinant extracellular portion of Dll4 (rhDLL4) was sufficient to down-regulate CXCR4 mRNA and protein, whereas protein levels of SDF1, VEGF, and RDC1 were unchanged. The gamma-secretase inhibitor L-685,458 significantly reconstituted CXCR4 mRNA in rhDLL4-stimulated endothelial cells. CXCR4 mRNA levels were significantly reduced in mouse xenografts of Dll4-transduced human gliomas compared with control gliomas, and vascular CXCR4 was not detected by immunohistochemistry in the enlarged vessels within the Dll4 gliomas. Thus, Dll4 may contribute to vascular differentiation and inhibition of the angiogenic response by regulating multiple receptor pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339870     DOI: 10.1158/0008-5472.CAN-07-2181

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation.

Authors:  Kira Orlovsky; Alexander Kalinkovich; Tanya Rozovskaia; Elias Shezen; Tomer Itkin; Hansjuerg Alder; Hatice Gulcin Ozer; Letizia Carramusa; Abraham Avigdor; Stefano Volinia; Arthur Buchberg; Alex Mazo; Orit Kollet; Corey Largman; Carlo M Croce; Tatsuya Nakamura; Tsvee Lapidot; Eli Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 3.  Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

Authors:  Zhi Huang; Lin Cheng; Olga A Guryanova; Qiulian Wu; Shideng Bao
Journal:  Protein Cell       Date:  2010-07-29       Impact factor: 14.870

4.  Notch1 deficiency results in decreased inflammation during wound healing and regulates vascular endothelial growth factor receptor-1 and inflammatory cytokine expression in macrophages.

Authors:  Hasina Hamilton Outtz; June K Wu; Xing Wang; Jan Kitajewski
Journal:  J Immunol       Date:  2010-08-25       Impact factor: 5.422

Review 5.  Brain tumor stem cells: Molecular characteristics and their impact on therapy.

Authors:  David L Schonberg; Daniel Lubelski; Tyler E Miller; Jeremy N Rich
Journal:  Mol Aspects Med       Date:  2013-07-04

6.  Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma.

Authors:  Ya-Ming Meng; Jing Liang; Chong Wu; Jing Xu; Dan-Ni Zeng; Xing-Juan Yu; Huiheng Ning; Li Xu; Limin Zheng
Journal:  Oncoimmunology       Date:  2017-12-13       Impact factor: 8.110

Review 7.  Modulating the stem cell niche for tissue regeneration.

Authors:  Steven W Lane; David A Williams; Fiona M Watt
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

8.  Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4.

Authors:  Yao-Chun Wang; Xing-Bin Hu; Fei He; Fan Feng; Lin Wang; Wei Li; Ping Zhang; Duan Li; Zhan-Sheng Jia; Ying-Min Liang; Hua Han
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

9.  Upregulation of stromal cell-derived factor 1 (SDF-1) expression in microvasculature endothelial cells in retinal ischemia-reperfusion injury.

Authors:  Pinghong Lai; Tao Li; Jun Yang; Chengyang Xie; Xiaobo Zhu; Hui Xie; Xiaoyan Ding; Shaofen Lin; Shibo Tang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-16       Impact factor: 3.117

10.  Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth.

Authors:  Marta Segarra; Cassin Kimmel Williams; Maria de la Luz Sierra; Marcelino Bernardo; Peter J McCormick; Dragan Maric; Celeste Regino; Peter Choyke; Giovanna Tosato
Journal:  Blood       Date:  2008-06-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.